Showing results (241-250 of 1,289) with videos related to
Sort By:
Pageof 129
Journal of Comparative Effectiveness Research|December 15, 2025
Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparisonTodd Bauer, Devin Abrahami, Anna Polli, et al.Journal of Comparative Effectiveness Research|December 9, 2025
Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trialAnia C Muntau, Sarah Gallagher, Melissa Lah, et al.Journal of Comparative Effectiveness Research|December 17, 2024
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from ChinaHua Zhong, Jun Lu, Mengzhao Wang, et al.Journal of Comparative Effectiveness Research|February 26, 2025
Evaluation of reporting in time-driven activity-based costing studies on cardiovascular diseases: a scoping reviewNayê Balzan Schneider, Erica Caetano Roos, Miriam Allein Zago Marcolino, et al.Journal of Comparative Effectiveness Research|February 17, 2025
The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countriesTommy Andersson, Hannes Nordmeyer, Waleed Brinjikji, et al.Journal of Comparative Effectiveness Research|January 17, 2025
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumabL Johnetta Blakely, Sabine Oskar, Ian Kudel, et al.Journal of Comparative Effectiveness Research|January 21, 2025
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summaryYulia Dinikina, Marina Dorofeeva, Fatima NakhushevaJournal of Comparative Effectiveness Research|December 4, 2024
Hospital readmissions following catheter ablation for atrial fibrillation with THERMOCOOL™ STSF/ THERMOCOOL™ ST catheter with CARTO™ 3 system versus TactiCath™ catheter with EnSite™ systemAlexandru I Costea, Rahul Khanna, Maximiliano Iglesias, et al.Journal of Comparative Effectiveness Research|September 3, 2024
One-year budget impact of InTandem™: a novel neurorehabilitation system for individuals with chronic stroke walking impairmentKirsten E Smayda, Jennifer Lavanture, Megan Bourque, et al.Journal of Comparative Effectiveness Research|November 19, 2024
Improving access to gene therapies: a holistic view of current challenges and future policy solutions in the United StatesTyler D Wagner, Lisabeth Buelt, Kimberly Westrich, et al.Pageof 129